Latest Announcements

BSE & NSE corporate filings with AI summaries

BSECompany UpdateMgmt Change4 Nov 2026

AUROBINDO PHARMA LIMITED

AUROBINDO PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" >&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Aurobindo Pharma Limited has informed the BSE about the re-appointment of a Non-Executive Independent Director.

BSECompany UpdateMgmt Change4 Nov 2026

AUROBINDO PHARMA LIMITED

AUROBINDO PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" >&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Aurobindo Pharma Limited has informed the BSE about the re-appointment of a Non-Executive Independent Director.

BSECompany UpdateMgmt Change4 Nov 2026

AUROBINDO PHARMA LIMITED

AUROBINDO PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" >&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Aurobindo Pharma Limited has informed BSE about the re-appointment of a Non-Executive Independent Director.

BSECompany UpdateMgmt Change4 Nov 2026

AUROBINDO PHARMA LIMITED

AUROBINDO PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" >&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Aurobindo Pharma has informed about the re-appointment of a Non-Executive Independent Director.

BSECompany UpdateMgmt Change4 Nov 2026

AUROBINDO PHARMA LIMITED

AUROBINDO PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" >&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Aurobindo Pharma Limited has informed BSE about the re-appointment of a Non-Executive Independent Director.

BSECompany UpdateInsolvency4 Nov 2026

Radhagobind Commercial Ltd

Outcome of COC meeting held on 04-11-2026

Radhagobind Commercial Ltd has announced the outcome of the 12th meeting of the Committee of Creditors (CoC) under the Corporate Insolvency Resolution Process (CIRP). The meeting was held on November 4, 2026, and the CoC approved various agenda items, including the voting procedure for Resolution Plans, the setting up of a Monitoring Committee, and the determination of the Resolution Professional's incentive.

Read more →📎 1 attachment
BSEBoard MeetingResults4 Nov 2026

Transindia Real Estate Ltd

The Board Meeting of the Company is being held today, i.e. on Wednesday, November 04, 2026. Pursuant to Regulation 30 and Regulation 33 read with Schedule III of SEBI Listing Regulations, the Board has considered and approved the matters amongst others as enclosed. The meeting commenced at 04:05 p.m. (IST) and concluded at 07:15 p.m. (IST). This intimation shall be uploaded on the Company's website at www.transindia.co.in. Kindly take the same on your records.

Transindia Real Estate Ltd has announced its board meeting outcome, approving unaudited financial results for Q2 FY2026-27, noting the retirement of its MD, and appointing a new executive director.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults4 Nov 2026

Chemplast Sanmar Ltd

Investor Presentation - Q2 & H1 FY''27

Chemplast Sanmar Ltd has released its Q2 & H1 FY'27 investor presentation, highlighting a 28% year-on-year growth in consolidated revenue to Rs. 1,323 crores, driven by robust domestic demand in the speciality segment and improved PVC prices in the commodity segment.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults4 Nov 2026

TCC Concept Ltd

Investor Presentation is attached.

TCC Concept Ltd has released its Q2 FY27 investor presentation, highlighting strong financial delivery with revenue from operations increasing by 396% YoY to INR 134 Cr, EBITDA by 160% YoY to INR 55 Cr, and PAT by 138% YoY to INR 25 Cr. The company has also announced a stock split, with shareholders approving the subdivision of 1 equity share of FV ₹10 into 5 equity shares of FV ₹2 each.

Read more →📎 1 attachment
← PreviousPage 549 of 10926Next →